Curegene Alternatives & Competitors

12 companies similar to Curegene — Advancing antiviral, cardiovascular, and cerebrovascular treatments with leading...

Arcturus Therapeutics

A messenger RNA medicines company focused on the development of liver and respiratory rare...

155 Grant $489.58M

San Diego, United States

Biotechnology Health Care +1

GamaMabs Pharma

Advancing the future of immuno-oncology with innovative monoclonal antibody treatments

7 Series B $18.10M

Biotechnology Health Care +1

IXALTIS SA

DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS

2 Venture round $8.00M

Toulouse, France

Biopharma Biotechnology +4

Expansion Therapeutics

Bringing transformative therapies to patients with severe RNA-mediated diseases.

29 Venture round $142.22M

Jupiter, United States

Biotechnology Health Care +1

Track all Curegene competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Altay Therapeutics

Unlocking Transcription Factors to Address Unmet Medical Need

6 Seed $3.37M

San Francisco, United Sta...

Biotechnology Health Care +3

etherna

Enabling Nucleic Acid Medicines for Next‑Generation Therapies | www.etherna.be

97 Series B $104.90M

Niel, Belgium

Biotechnology Health Care +2

Petra Pharma

Pioneering novel therapies to address cancer and metabolic disorders by targeting essentia...

Debt Financing $75.55M

Biotechnology Health Care +2

Astex Pharmaceuticals

Committed to the fight against cancer and CNS disorders

136

Cambridge, United Kingdom

Biotechnology Health Care +2

Palatin Technologies

We discover and develop novel therapeutics for patients living with inflammatory and autoi...

50 Post-IPO Equity $133.90M

Biotechnology Health Care +1

Lassen Therapeutics

Combining innovative science, leading technology, and unmatched know-how to create novel m...

11 Series B $116.00M

San Diego, United States

Biotechnology Health Care +2

iVascular

From the heart

307

Germany

Biotechnology Health Care +2

Myrobalan Therapeutics

Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS...

27 Grant $24.40M

Medford, United States

Biotechnology Health Care +1

About Curegene

Curegene is a biotech startup established in 2018 with a strong focus on developing innovative treatments for anti-viral, cardiovascular, and cerebrovascular diseases. The company's commitment is emphasized in its slogan, "Advancing antiviral, cardiovascular, and cerebrovascular treatments with leading prodrug and nucl...

Taxonomy

Pharmaceuticals, Prodrug Technology, Nucleic Acid Drugs, Antiviral Treatments, Cardiovascular Treatments, Cerebrovascular Treatments, Small Molecules, Medical Research, Drug Development

Frequently Asked Questions

Companies similar to Curegene include Arcturus Therapeutics, GamaMabs Pharma, IXALTIS SA, Expansion Therapeutics, Altay Therapeutics. They work in Health Care and Health and Wellness and share Curegene's focus on drug development, pharmaceuticals and medical research.

Bounce Watch lists 12 companies that share Curegene's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Curegene and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Curegene Profile GamaMabs Pharma Alternatives IXALTIS SA Alternatives Expansion Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Curegene on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.